The Post-Buzzword Drug Discovery Platform
That Actually Works Better Than Any Other in Existence
Virtual exploration of chemical space spanning 1033 drug-like compounds
Ab initio quantum & semi-classical physics modeling of protein-drug interactions
Streamlined synthesis driven by computer-generated pathways
Integrated biological characterization & AI-based optimization
Virtual exploration of chemical space spanning 1033 drug-like compounds
Ab initio quantum & semi-classical physics modeling of protein-drug interactions
Streamlined synthesis pathways driven by computer-generated instructions
Integrated biological characterization & AI-based optimization
You have just read a simplified description of our process. The full platform utilizes a wide range of fundamental scientific breakthroughs developed in-house over 20 years. We could go on telling you about our advances in synthetically tractable molecule creation, our breakthroughs in modeling of molecular physics, our ability to generate data far beyond what is accessible to the rest of the industry, the limitations of current pure AI-driven models and how we overcame them, and the many advances across diverse scientific disciplines required to truly transform small-molecule drug discovery and development.
But we won’t.
Our platform just works.
If you really want to know more details about our platform, contact us.
“Evidence that Verseon's approach works has accumulated across various disease areas over several years…
Every program features multiple chemically diverse clinical candidates – a feat unheard of in the pharmaceutical industry.”
“Verseon … is beginning to fill in the map of uncharted drug discovery space. In effect, it is replacing the void of ‘here be dragons’ (as one 16th-century mapmaker warned) with islands of known entities.”